Finance

Beta
Lists
RGT:ASX
Argent BioPharma Ltd
A$0.036
0.00%
(0.00) 1D
Jun 4, 2:12:47 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RGT...
Mkt. cap
4.00M
Avg. vol.
38.23K
Volume
0.00
52-wk high
A$0.32
52-wk low
A$0.03
EPS
-A$0.13
Shares outstanding
111.11M
Mkt. cap
4.00M
Avg. vol.
38.23K
Volume
0.00
52-wk high
A$0.32
52-wk low
A$0.03
EPS
-A$0.13
Shares outstanding
111.11M
News stories
From sources across the web
About Argent BioPharma Ltd
CEORoby Zomer
Employees-
Founded2005
Headquarters-
SectorPharmaceutical industry
Websiteargentbiopharma.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
88.14K
88.14K
85.75K
85.75K
Cost of goods sold
388.92K
388.92K
103.51K
103.51K
Cost of revenue
388.92K
388.92K
103.51K
103.51K
Research and development expenses
1.48M
1.48M
201.15K
201.15K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.23M
2.23M
1.26M
1.26M
Operating expense
3.14M
3.14M
1.47M
1.47M
Total operating expenses
3.53M
3.53M
1.58M
1.58M
Operating income
-3.44M
-3.44M
-1.49M
-1.49M
Other non operating income
314.34K
314.34K
66.88K
66.88K
EBT including unusual items
-2.84M
-2.84M
-1.47M
-1.47M
EBT excluding unusual items
-2.95M
-2.95M
-1.44M
-1.44M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-571.83K
-571.83K
13.05K
13.05K
Net income
-2.84M
-2.84M
-1.47M
-1.47M
Net profit margin
-3,223.54%
-3,223.54%
-1,711.52%
-1,711.52%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-10.06K
-10.06K
-16.75K
-16.75K
Net interest expenses
-10.06K
-10.06K
-16.75K
-16.75K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.40M
-3.40M
-1.47M
-1.47M
Gain or loss from assets sale
61.97K
61.97K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer